Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-064754
Filing Date
2025-07-01
Accepted
2025-07-01 16:31:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8808
2 EXHIBIT I tm2519595d1_ex-1.htm EX-99.1 4516
  Complete submission text file 0001104659-25-064754.txt   15208
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

EIN.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Subject) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-82196 | Film No.: 251096852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)